lants are essential for human life and culture. They are used as food, fodder, medicines, and a vast array of craft and building materials, in ways determined by both plant biology and culture. Throughout history, plant diversity shaped cultural practices, and in turn, humans shaped plant diversity by domesticating and translocating plant species, or caused them to go extinct. Diverse wild and cultivated plant species have a high impact on societies' well-being through their incorporation in healthcare 1 . Here, we propose a cultural macroevolutionary framework to study the use of plants in ethnomedicine. Anthropologists have used phylogenetic comparative methods (PCMs) to gain increasingly sophisticated understanding of the evolution of various aspects of culture. Despite a wealth of data in ethnobotanical and ethnographic literature, and recognition of the role of cultural identity in medicinal plant species preferences [2] [3] [4] [5] [6] , PCMs have scarcely been applied to understand cultural diversity in medicinal plant use. Current rates of biological and cultural diversity loss are threatening ecosystems, as well as human well being 7 . Simultaneously, intangible cultural heritage, including knowledge about medicinal plants, is quickly being lost to acculturation (for examples see refs [8] [9] [10] ). This rapid change makes studies capturing the relationship between cultural evolution and plant-use particularly timely. These approaches are also realisable for the first time, using large-scale databases that integrate language phylogenies with cultural, environmental and ecological data, are now readily and freely available 11 . In this Perspective, we outline how questions relating to the transmission of medicinal plant use and knowledge are particularly amenable to PCMs, considering individual plant species and plants as components of whole ethnopharmacopoeias.
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Biologists explain the origins and maintenance of trait differences amongst lineages of organisms using PCMs 12 .
To do this, they use phylogenies to estimate species relationships, usually based on DNA sequence data. Combined with morphological, physiological, behavioural or other trait data that is mapped onto the ensuing evolutionary trees, hypotheses about the patterns and processes of trait evolution can be tested 13 . Increasingly, anthropologists interested in cultural macroevolutionary processes are using PCMs to understand the history of human populations and the dynamics of cultural traits. In anthropology, the phylogenetic relatedness of ethnolinguistic groups is inferred through analysis of linguistic (rather than genetic) data, and the distribution of cultural traits is investigated [14] [15] [16] [17] . Human populations (cultures, languages, societies) are phylogenetically non-independent, a fact recognised as 'Galton's problem' in cross-cultural studies for over 100 years 18 . The adoption of PCMs as a tool for cross-cultural analysis 19 has allowed for robust statistical accounting of shared history, and these methods have significantly advanced understanding of the origins and diversification of political, religious, social and material culture [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Just as in the biological sciences, a multiplicity of PCMs are applied in anthropology and linguistics to determine whether traits have multiple origins, whether pairs of traits are co-evolving, to infer ancestral states, and to characterize the mode and tempo of trait evolution. Traits can also be mapped in space, considered for their joint dynamics, and their correlations with environmental variables can be explored 11, [21] [22] [23] [24] . The few uses of PCMs to understand how elements of biodiversity are differently exploited cross-culturally have focused on plant-based subsistence traits. Mace and Jordan 25 included the presence or absence of grain, root/tuber or tree crops in a wider study of the role of ancestry and geographic proximity in the diversification of Austronesian cultures, and found that, when controlling for relatedness, geographical proximity predicted whether societies shared crop types. Currie and Mace 26 used PCMs to infer the relative evolutionary rates of cultural change, showing that crop type was an average-changing cultural feature across both Austronesian and Bantu societies. Although focussing on species rather than life forms when using PCMs for cross-cultural comparison is challenging, the potential for better understanding of cultural and plant-use evolution is enormous.
Here, we explore three main applications of PCMs, the first two using phylogenetic relatedness of ethnolinguistic groups to explore the origins and evolutionary relationships of ethnobotanical features, and the third exploring the drivers of overall similarity in ethnofloras (Box 1). Mapping and ancestral reconstructions of features (Box 1.1), such as the use of specific plants, allows us to examine cultural change while accounting for Galton's problem. In terms of the use of specific plants, at the heart of such a study is the question 'is shared plant-use homologous?' We will explore the concept of homology, showing how it can usefully be applied to better understand the use of plants in medicine. The second application explores correlated evolution (Box 1.2). Here, we consider how explicit tests of co-evolution of ethnobotanical features might permit deeper understanding of the wider context of plant use. The third application uses methods that consider the relatedness of the whole ethnoflora (Box 1.3), opening new lines of investigation into the drivers of the phylogenetic composition of ethnofloras. Environmental data are of particular interest as potential drivers, for example, vegetation type has long been suggested as a factor shaping the composition of ethnopharmacopoeias 27 . Therapeutic needs, expected to drive plant-use, might also co-vary with some environmental parameters. High-resolution environmental data are used increasingly by evolutionary anthropologists to determine the role of ecology as a driver of cultural practices 11 . Whether focusing on single plant species and using methods to test for correlated evolution (Box 1.2), or for assessing the drivers of the composition of whole ethnofloras (Box 1.3), wider application of PCMs to ethnobotanical and environmental data has potential for fruitful new research directions.
Macroevolutionary studies and medicinal plant use
Macroevolutionary studies explore evolutionary processes occurring at time scales far exceeding the human lifespan, based on the observation of patterns observed above the species level. In contrast, microevolutionary studies are of adaptive processes that can be observed in nature or the laboratory 28 . Our proposal to use PCMs in the study of medicinal plants borrows techniques of macroevolutionary biology that are also applied by evolutionary anthropologists. These PCMs complement established microevolutionary observations of medicinal plant use. For example, processes of botanical-knowledge adaptation have been studied in depth among migrant populations, who adopt both conservative and innovative strategies by importing plant species from their home environments as well as using plants from the new flora (for examples see refs [29] [30] [31] [32] [33] ). Innovation through the incorporation of individual plants sourced through cultural exchange and trade (such as plants traded from Features might include use of specific plant species, modes of application or preparation or perceptions of plant properties.
• Was plant X adopted for medicinal use once or multiple times?
• Has use of plants as fumigants originated once or multiple times?
• Has the perception of the humoral properties of plant X originated once or multiple times?
(2) Correlated evolution: do ethnobotanical features evolve together?
Features might include use of specific plant species, healing techniques or illness aetiologies.
• Do illness aetiologies (for example, ritual treatments) and specific treatments (for example, use of plants as fumigants) co-evolve?
• Is there turnover in the use of plant species but conservation of healing techniques, or do they co-evolve?
• Do ethnopharmacopoeias evolve as systems, or are plants adopted independent of any others? Putative drivers could include any quantitatively measurable factor that could be used to create distance matrices, such as floristic environment, proximity of peoples or climate variables, or qualitative, intrinsic factors such as belief systems.
• Can intrinsic factors, such as belief systems, or extrinsic factors explain similarity in ethnofloras?
• Do societies use similar or closely related plants for similar therapeutic applications?
In (1) and (2), PCMs are used to examine cultural change while accounting for Galton's problem. In (3), community phylogenetic methods to describe the overall similarity of ethnopharmacopoeias, and putative drivers of overall similarity identified.
Box 1 | Types of research questions regarding medicinal plant use that are enabled by PCMs.
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Asia to the Mediterranean 34 ) are observed adaptations. Textual evidence can also provide insights into transmission or adaptation of knowledge at the timescale of written records. For example, comparison of historical materia medica with more contemporary texts or records can identify plant-use combinations that have experienced 'mutation' and 'selection' 35 , with the caveat that the texts themselves shape the use of plant-based medicines 36 . Increasingly, researchers are studying the transmission of medicinal plant-use knowledge within communities using social learning strategies identified by cultural microevolutionary theorists 35, [37] [38] [39] [40] . It has been suggested that some medicinal uses of specific plants may be based on prolonged experimentation of a society in a particular location, reflecting long-term and relatively static interaction with the floristic environment 41 . The possibility that long-term vertical transmission of knowledge might be on the timescale at which ethnolinguistic groups diverge, raises questions that are resonant with those that evolutionary anthropologists have asked regarding the evolution of other cultural traits. Nonetheless, PCMs have only recently been suggested as means to understand the origins of the use of specific species and to determine whether or not knowledge about plant-use is inherited, culturally diffused or independently adopted by different societies 42 . PCMs would allow researchers to systematically address questions about cross-cultural diversity and changing medicinal plant knowledge, at the timescale at which ethnolinguistic groups diverge and in the absence of textual evidence.
Homology criteria for cultural traits
Similarity due to shared ancestry is referred to as homology in biological systematics 43 . Despite the diversity of applications of phylogenetic methods in evolutionary anthropology 44 , conceptual issues surrounding homology have largely been the concern of archaeologists and scholars inferring phylogenetic trees from material culture, such as tool technologies 45, 46 . In the twentieth century anthropologists, such as Steward 47 , articulated criteria for homologous cultural traits such as geographic proximity, quantity of shared traits and uniqueness, but these suggestions were not taken forward in hypothesis-testing frameworks. We suggest that combining the rich literature from biological sciences describing how hypotheses of homology are tested with the concerns articulated by cultural evolutionary archaeologists provides a useful approach to consider the relationship between different sources of evidence.
For biological structures, similarity and congruence tests are used to differentiate parallelism, convergence and homology 43, [48] [49] [50] . The similarity test for structures is based on observations of topographic (positional) correspondence and ontogenetic (developmental and compositional) similarity. The congruence test describes whether an attribute has a single origin in a phylogeny (is congruent or homologous), or multiple origins (is incongruent or not homologous). If homology is continuity of form, then continuity must be positional (for example, structures found to be homologous must all be in the axis of a leaf), ontogenetic/compositional (for example, structures found to be homologous are all spiny, resulting from the hardening and senescence of an axillary shoot) and phylogenetic (for example, homologous structures are shared, derived characters or are markers of a clade that have axillary spines as a defining feature).
There are important disanalogies between cultural and biological processes 16, 51 , even so, multiple sources of evidence could also be incorporated in studies of medicinal plants, and relations differentiated depending on multiple tests. When species are used medicinally across cultures there are at least four sources of evidence-aside from written records and examination of historical and archaeological collections-which are informative of the origins of plant use (Table 1) . We suggest here how ancestry (vertical transmission), independent discovery (convergence) and cultural diffusion (horizontal transmission) might be characterised by linguistic, geographic and use tests, whilst a congruence test using an explicit phylogenetic framework ultimately provides evidence of historical continuity.
Firstly, by analysing sets of plant names, historical linguistics may provide evidence of the phylogenetic and therefore temporal depth of plant use or knowledge 52 . Historical linguists refer to linguistic homology as cognacy; cognates are words that share form and meaning due to common descent. Reconstructions of the phylogenetic depth of cognates across ethnolinguistic groups are commonly applied in studies of translocated plant species, typically domesticates [53] [54] [55] but sometimes other culturally, ecologically or economically important species 52, 56, 57 . This method is not a single diagnostic test, as closely-related languages can independently innovate terms that are similar in form and meaning while not sharing a descent relationship 58 , and unless applied with caution, historical linguistic reconstruction can attribute greater time depth than warranted when words have been borrowed 59 . Secondly, aspects of plant-use can be used as a source of evidence. Usage encompasses the parts of the plants used, the modes of preparation, and the modes of administration or application, each per therapeutic application. Medicinal applications are described both by standard scientific use categories and by the emic rationale (that is, culturally meaningful categories 60 ). For example, the emic category of asumid or 'cold' used among Amazigh communities in Morocco encompasses ailments ranging from musculoskeletal, gynaecological and respiratory etic categories 61 . The similarities and differences of how plants are prepared and administered, and for what end, will therefore contribute to understanding of historical plant use. Moreover, a plant may be used across multiple cultural domains beyond healing, such as religion, textiles and diet. Variation in the breadth of use of a plant across cultural domains can also be indicative of a shared source of knowledge between different societies, whether through ancestry or cultural diffusion. Thirdly, accounting for peoples' geographical distribution and trading relationships is important, since direct horizontal transmission is possible between distantly related Considering any plant species and its use across ethnolinguistic groups of known relationship, these tests may discriminate different modes of transmission and independent discovery. The use of cognate names and congruent plant uses (such as the same plant part, mode of application and therapeutic application) are similar, indicating non-independence. The phylogenetic (congruence) test, interpreted alongside proximity, discriminates between horizontal and vertical transmission. In biological systematics, characteristics passing similarity and congruence tests are referred to as homologies. We refer to homology to discriminate common ancestry from alternative explanations of shared use, noting that the relative importance of different explanations for sharing is of interest and that cultural traits lack the physical continuity of information from biological organisms.
cultures only if they are in proximity 62 or have established trade relationships 34, 63 . Finally, phylogeny to account for cultural relatedness is an important test since shared ancestry is an explicit indicator of vertical transmission. The existence of inference of plant-use in ancestral communities ('proto-languages' on language phylogenies) can indicate whether shared use pre-dates divergence of those ethnolinguistic groups.
Our scheme supposes that ancestral use is characterised by the use of cognate plant names, and similar therapeutic applications and modes of use, among linguistically related societies. Linguistic and use tests may not be sufficient to determine ancestry, since both names and specific plant uses may change through time despite continuity of use. Considering one pair of ethnolinguistic groups in Mesoamerica, Lowland Mixe and Zoque-Popoluca, Leonti et al. 64 found nine cognate names for 123 shared medicinal plants, of which 62 had a similar usage, suggesting relatively rapid linguistic divergence. As case studies accumulate, the frequency of linguistic divergence or divergence in uses can be estimated when phylogenetic tests are indicative of ancestral use (Fig. 1) . Linguistic divergence could differ between different categories of plant use. Chirkova et al. 65 considered five Chinese ethnolinguistic groups, using plant names to corroborate hypotheses of ethnolinguistic relatedness. They found shared plant names were most common for plants with ritual use, or those with low cultural significance (plants that were not field crops, fruit trees or used as fodder, food, fuelwood, or in medicine or ritual). The former pointed to sharing of ritual practices, the latter was interpreted as borrowing of names from the indigenous language for items of acculturation encountered on migration since the local ethnic groups were 'newcomers' in the area 65 . In another study, suggesting phylogenetic distribution of cognate plant names might be indicative of migration history, Bostoen et al. 52 used a phylogeny of Bantu languages to explore the names of plants characteristic of forest environments in order to infer historical occupations of forested environments. Linguistic and use tests may be of particular value when the phylogenetic test is suggestive of independent discovery or cultural diffusion. Linguistic tests may distinguish independent discovery from cultural diffusion, since the latter can be characterised by the use of loanwords 66, 67 , whereas therapeutic applications and modes of application of a species might converge in the case of independent discovery.
The use of PCMs in cultural anthropology has been critiqued by those arguing that cross-cultural diffusion or rapid adaptation may invalidate the use of tree-based, hierarchical methods 51, 68 . The validity of these critiques depend on the timescale of cultural evolution under consideration, the nature of the research question (in the absence of very rich textual data, inferring ancestral traits and determining models of trait evolution are only possible using phylogenies), and the nature of the traits themselves 16, 23 . Accounting for variance imposed by hierarchical population structure is critical for any investigation of cultural diversity, whether with PCMs or standard multilevel modelling methods. Using explicit phylogenetic hypotheses (or Bayesian posterior sample of phylogenies) formalises the identification of independent evolutionary events and of horizontal transmission itself 25 . Furthermore, simulation studies, such as Greenhill et al. 69 and Nunn et al. 70 , show that the statistical impact of borrowing and diffusion depends on the global versus 'local' nature of the borrowing. Local borrowing between sister populations-in principle, the most common kind-should not invalidate tree-based methods 69 . An explicit phylogenetic framework opens up the possibility of a synthetic, macro-scale research programme that documents the extent to which there are global patterns in dissociation of names and uses, identifying drivers of dissociation where plant species have apparently ancestral use in medicine.
Tests for correlated evolution
PCMs were originally developed to test adaptationist ideas, and can help tackle several key questions about the co-evolution of material and immaterial aspects of plant use. These include the definition of illnesses treated (for example, classified according to their aetiology) 71 and techniques associated with herbal practice (such as preparation and application modes), in addition to co-variation in the plant materials themselves (the floristic composition of the ethnopharmacopoeias 72, 73 ). For example, the choice of therapy, therapist and therapeutic application of plants may be determined by beliefs around symptomatology and aetiology 6, [74] [75] [76] [77] . Furthermore, Vossen et al. 33 and Teixidor-Toneu et al. 76 observed in disparate study sites (South America and north Africa) that treatment systems and illness aetiologies seem to be more conserved than treatment materials themselves, but hypotheses regarding differential change of aspects of medical systems over time have yet to be formally tested.
PCMs explicitly testing for correlated evolution might also consider which plant species have shared histories. Borrowing the idea that cultures may have 'core traditions' and 'peripheral elements' Ellen and Puri 78 identify a 'core' of medicinal plants in ethnopharmacopoeias that represent a shared ethnomedicinal tradition across societies. However, whether elements of ethnopharmacopoeias are transmitted individually, or sets of plants share cultural histories, is yet to be tested. Where ethnolinguistic phylogenies are used as the framework for hypothesis testing, it becomes possible to estimate the degree of vertical (ancestor-descendant) versus horizontal (diffusion) transmission or independent innovation 51 , since these might differ between different component characteristics of items of (material) culture 79 . Ideally, the aim is for wider tests of the supposition, put by Borgerhoff Mulder et al. 51 , that most traits will exhibit a combination of horizontal and vertical transmissionwith horizontal transmission dominating at some times and vertical transmission at others 69 -where species or plant lineages are the traits of interest.
Whole pharmacopoeias
Beyond exploring the cultural histories of specific medicinal plants or remedies, ethnopharmacopoeias or medicinal floras can be studied as a whole. Ethnobotanists have used a range of quantitative measures to compare pharmacopoeias across societies, from directly scoring the number of shared species 78, 80 to using biological diversity measures, such as the Jacquard index 81 or consensus analysis indices [82] [83] [84] . However, these measures are limited by the degree of overlap between the floras compared. Since plants are phylogenetically related to each other, community phylogenetic methods overcome this limitation and allow for comparisons at any taxonomic level 5, [85] [86] [87] . They are justified because closely related plants are chemically similar and may have the same pharmacological properties 88, 89 . The use of a plant species in one ethnopharmacopoeia, but a related species in another, may represent real similarity in ethnofloristic composition. Community phylogenetic measures allow for this similarity to be reflected in comparative measures, opening up the possibility of broader or even global studies of ethnofloristic relatedness. Such an approach could also be useful to overcome some methodological limitations with PCMs. Current methods allow us to study the dynamics of single traits or coevolving pairs, but are not yet capable of comparing the multiple species combinations present in ethnopharmacopoeias.
In the first study to use a linguistic phylogeny to represent cultural ancestry and a phylogenetic measure of the similarities of ethnopharmacopoeias, Mantel tests were used to explore whether relatedness of ethnofloras was correlated with cultural relatedness 5 . The study also considered the effects of: geographic proximity, assessing potential for cultural diffusion; floristic environment, considering the environmental affordances; and similarity due to shared linguistic ancestry, addressing Galton's problem. An important caveat of studies evaluating multiple traits is the risk of over interpreting P-values in terms of strength of evidence for a particular pattern or refuting null hypotheses 51 . Indeed, Saslis-Lagoudakis et al. 5 highlighted the significant impact of floristic environment, though ancestry also showed a positive correlation with composition of the ethnopharmacopoeia. Teasing apart the species, plant lineages or uses that are inherited through different transmission channels or at different rates is a step-up in analytical complexity, but new hybrid model selection approaches that incorporate phylogenetic structure into multi-model inferences may provide appropriate tools.
One important caveat when considering applications of this kind is that the recognition of what constitutes the set of medicinal plants for any ethnolinguistic group may be problematic. Compilations from literature, or data from focussed fieldwork, may include plant species that are widely and frequently used along with species that perhaps have only one reported known-use. Where PCMs are applied to single plant species or aggregates of species, to investigate homology of use or features correlated with use, then conflating important with less important species would not influence the outcome of the analysis. However, where a whole ethnoflora is under consideration, and quantitative measures of the similarity between ethnofloras are made, metrics may be strongly influenced by whether or not rarely used plant species are included. This issue was explored by Souza et al. 90 , who developed weighted metrics to take into account the number of use-reports for any species. Approaches of this kind address the problem of rarely used species being inconsistently recorded.
Implementation challenges
Floristic checklists are needed to explicitly consider the role of the floristic environment on medicinal plant use, and floristic composition is explicitly a variable when considering whole floras. Analyses of the depth and origin of specific plant remedies will always be constrained by the distribution of the plants, whether naturalised, native or imported, making floristic checklists and distribution maps necessary. The definition of a plant's area of distribution will depend on the species or ethno-species definition used, at least for some herbal remedies. Primary information on medicinal plant use is collected in emic terms, and the definition of plant species used by individuals in culture-specific ways do not always correspond one-to-one with scientific botanical species 91 . A vernacular plant name can be used for more than one botanical species, or alternatively, a single botanical species can represent more than one ethnospecies 91 . Although this is a caveat that remains mostly unacknowledged in ethnobotanical comparative studies, it is central to the analyses proposed here. One herbal remedy can maintain its vernacular name and use across a broad area, but refer to different botanical species with reduced areas of distribution 92 . Whilst it is not possible to meaningfully take this into account in comparative studies of whole pharmacopoeias based on phylogenetic relationships between plants, analyses of individual plants or remedies should critically define and justify one or other approach.
Anthropology and linguistics are undergoing their own 'informatics' revolution, and recent advances have made the construction and availability of large data resources widespread 20 . eHRAF (http:// ehrafworldcultures.yale.edu/ehrafe/), D-PLACE 11 , Glottolog 93 , Seshat 94 , and various initiatives from the Glottobank and CLLD consortia 95 , make cultural and linguistic data more accessible than ever. In particular, language phylogenies for at least ten large and widely geographically spread families are readily available from D-PLACE 11 , including Indo-European, Bantu and Austronesian. Phylogenetic linguistics is a fast-growing field, and new language family trees, derived by cutting-edge Bayesian phylogenetic inference, emerge regularly. In contrast, the systematic availability of corresponding ethnobotanical field data may be a major limitation.
No compilation of medicinal plant uses across the globe is available and ethnobotanical data is dispersed in multiple separate publications. Documentation efforts are extensive in some areas and partial or almost non-existent in others 96, 97 ; absence of data may be a result of absence of fieldwork in a particular region. On the one side, trustworthy botanical identifications are required 98, 99 ; on the other, ethnobotanical data may have been collected by scholars from different disciplines with different aims, which may result in biased views of local medical systems. For example, ethnopharmacological accounts are notorious for not giving enough context of the medical practices in which therapeutic materials are used, and lists provided may be restricted to a group of organisms 73, 78, 100 . Efforts are being made to set methodological guidelines and data standards, increasing the quality ethnobotanical and ethnomedicinal data collection and providing quality criteria for the selection of literature 60, 100 . Meanwhile, for some applications where whole ethnopharmacopoeias are considered, it might be appropriate to use large data sets compiled using data from herbarium vouchers to complement the ethnobotanical literature 101 .
Databases of medicinal plant uses are proposed as tools for crosschecking contemporary ethnopharmacological field-data and as repositories for data mining 102 . For these repositories to be most useful, they should include information about plant users, therapeutic context in which plants are used, emic descriptions of illness, illness aetiologies and plant species' vernacular names (and language) in addition to data on plant parts used, therapeutic application, preparation and mode of application. Such information should be gathered systematically and be compatible with other complementary cultural and linguistic large data resources (including refs 11, 93, 94 ).
significance and conclusions
This review highlights the potential of PCMs in particular, and cultural evolutionary theory in general, to address interdisciplinary questions about the variation and history of medicinal plant use. Whilst there is copious evidence for recent exchange and innovation of plant use that may lead to cross-cultural similarities (of which recent migrations are clear examples of transmission of knowledge), any historically deep medicinal plant use remains an assumption that, in the absence of textual evidence, can only be tested using PCMs. We have proposed a test combining four sources of evidence to distinguish homology (ancestral use) from cultural diffusion and independent discovery of plant uses. We have further explored the ways in which cultural evolutionary theory can be applied to questions of variation and transmission of knowledge about biodiversity. Finally, we highlight sources of data as well as data gaps and suggest a strategy for systematic data collection, necessary for further analysis.
This Perspective has focused on medicinal plants due to their importance for human well-being. However, this approach can inform other key related fields, such as food provisioning. A test for ancestry and independent discovery of medicinal plant uses may be of particular value when aiming to identify pharmacologically active plants, but understanding the mechanisms behind the inheritance and diffusion of used-plant diversity has much broader applications. Such meta-analyses are pressing due to the trends of loss of both biological and cultural primary data, and could help identify areas where more data are needed. The ensuing results could provide clues for the conservation of intimately linked biological and cultural systems.
